Liquidhope: methylome and genomic profiling from very limited quantities of plasma-derived DNA
Briefings in Bioinformatics · 2023
DOI: 10.1093/bib/bbac575 ↗Kurz gefasst
Fachartikel in der Zeitschrift Briefings in Bioinformatics, 2023. Verfasst von Eva María Trinidad und 8 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Cellular and Molecular Biology, Health Research Institute Hospital La Fe, Valencia, Spain. Hauptthemen laut MEDLINE: Neoplasms, Cell-Free Nucleic Acids. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Fundación Científica de la Asociación Española Contra el Cáncer, Instituto de Salud Carlos III (ISCIII), Spain and 'European Social Fund Plus (ESF+)' of the European Union, Spanish Ministry of Science and Innovation.
Abstract (Originalsprache)
Analysis of the methylome of tumor cell-free deoxyribonucleic acid (DNA; cfDNA) has emerged as a powerful non-invasive technique for cancer subtyping and prognosis. However, its application is frequently hampered by the quality and total cfDNA yield. Here, we demonstrate the feasibility of very low-input cfDNA for whole-methylome and copy-number profiling studies using enzymatic conversion of unmethylated cysteines [enzymatic methyl-seq (EM-seq)] to better preserve DNA integrity. We created a model for predicting genomic subtyping and prognosis with high accuracy. We validated our tool by comparing whole-genome CpG sequencing with in situ cohorts generated with bisulfite conversion and array hybridization, demonstrating that, despite the different techniques and sample origins, information on cfDNA methylation is comparable with in situ cohorts. Our findings support use of liquid biopsy followed by EM-seq to assess methylome of cancer patients, enabling validation in external cohorts. This advance is particularly relevant for rare cancers like neuroblastomas where liquid-biopsy volume is restricted by ethical regulations in pediatric patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Cellular and Molecular Biology, Health Research Institute Hospital La Fe, Valencia, Spain.
- Clinical and Translational Research in Cancer, Health Research Institute Hospital La Fe, Valencia, Spain.
- CNAG-CRG, Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology (BIST), , Barcelona , Spain.
- Universitat Pompeu Fabra (UPF), Barcelona 08002, Spain.
- Pediatric Oncology Unit, La Fe University Hospital, Valencia, Spain.
ORCID-Profile: Eva María Trinidad, Enrique Vidal, Esther Coronado, Anna Esteve-Codina, Victoria Castel, Adela Cañete, Marta Gut, Simon Heath, Jaime Font de Mora
Förderung
- Fundación Científica de la Asociación Española Contra el Cáncer
- Instituto de Salud Carlos III (ISCIII), Spain and 'European Social Fund Plus (ESF+)' of the European Union
- Spanish Ministry of Science and Innovation
- Instituto de Salud Carlos III (ISCIII), Spain and ‘European Social Fund Plus (ESF+)’ of the European Union
Zitieren
APA
Trinidad, E. M., Vidal, E., Coronado, E., Esteve-Codina, A., Castel, V., Cañete, A., Gut, M., Heath, S., & Font de Mora, J. (2023). Liquidhope: methylome and genomic profiling from very limited quantities of plasma-derived DNA. Briefings in Bioinformatics. https://doi.org/10.1093/bib/bbac575
Vancouver
Trinidad EM, Vidal E, Coronado E, Esteve-Codina A, Castel V, Cañete A, et al. Liquidhope: methylome and genomic profiling from very limited quantities of plasma-derived DNA. Briefings in Bioinformatics. 2023. doi:10.1093/bib/bbac575
BibTeX
@article{Trinidad2023,
author = {Trinidad, Eva María and Vidal, Enrique and Coronado, Esther and Esteve-Codina, Anna and Castel, Victoria and Cañete, Adela and Gut, Marta and Heath, Simon and Font de Mora, Jaime},
title = {Liquidhope: methylome and genomic profiling from very limited quantities of plasma-derived DNA},
journal = {Briefings in Bioinformatics},
year = {2023},
doi = {10.1093/bib/bbac575}
}
EUVIMED